Compound libraries
Products
EBC main page
Search
Dyes
Impurities
Chemical probes
Contacts us
Pfizer reference compounds
Services
© 2026 Copyright Enamine
Back
Product details:
CAS
231277-92-2
Purity
95%
Lapatinib is a 4-anilinoquinazoline kinase inhibitor of the intracellular tyrosine kinase domains of both epidermal growth factor receptor (HER1/EGFR/ERBB1) and human epidermal growth factor receptor type 2 (HER2/ERBB2). Lapatinib is an anti-cancer drug, used for the treatment for solid tumours such as breast and lung cancer.
Properties
Name
Lapatanib
Smiles
CS(=O)(=O)CCNCC1=CC=C(O1)C=2C=CC=3N=CN=C(NC=4C=CC(OCC=5C=CC=C(F)C5)=C(Cl)C4)C3C2
Targets
Please log in to see this information
SDS
GW-572016 | LAP | Lapatinib | apatinib | lapatanib | tykerb | tyverb
The compound has purity validated by NMR and/or LCMS methods.
1 mg
$19
2 mg
$19
5 mg
$19
10 mg
$19
15 mg
$19
20 mg
$19
25 mg
$19
30 mg
$19
35 mg
$19
40 mg
$19
45 mg
$19
50 mg
$19
75 mg
$19
100 mg
$POA
Quantity
1
Total amount
$ 19
GW-572016 | LAP | Lapatinib | apatinib | lapatanib | tykerb | tyverb
The compound has purity validated by NMR and/or LCMS methods.
Target activity features
It should be emphasized that the product may be active against a larger number of targets than shown on the card. The information represented here refers to the targets with the largest value of pX or the targets with ΔpX less than 1.5 from the largest pX value.
CAS:388082-78-8
0
CAS:1187538-35-7
0
CAS:231277-92-2
0